Resources

Results 1226 - 1250 of 1366

The Ministry of Health and Social Services in Namibia conducted a confirmatory assessment of the risk of anemia associated with zidovudine (AZT)-based highly active antiretroviral therapy (HAART) using records contained in three electronic databases. A total of 12,358 records were examined. We measured the sensitivity of the starting HAART regimen (the proportion of AZT users in the clinical record correctly identified in the electronic record), and specificity of severe anemia (the proportion of non-cases of severe anemia in the clinical records correctly identified in the electronic record). Probabilistic record linkage methods were effective for records linkage in this sub-Saharan African setting.

Of 48 surveyed hospitals and health centers in Ethiopia, 9 (19%), 9 (19%), and 10 (21%) did not have malaria, TB, or HIV drugs, respectively. Similarly, of 27 health posts, 9 (33%) and 6 (22%) did not have rapid diagnostic tests and antimalarial drugs, respectively. The findings indicated an inadequate availability of essential drugs and commodities in the surveyed facilities as well as weaknesses in human resources and training.

Low-income countries with high HIV/AIDS burdens in sub-Saharan Africa must deal with severe shortages of qualified human resources for health. This situation has triggered the renewed interest in community health workers, as they may play an important role in scaling-up antiretroviral treatment for HIV/AIDS by taking over a number of tasks from the professional health workers.

Background: The Ministry of Health in Malawi is implementing a pragmatic and innovative approach for the management of all HIV-infected pregnant women, termed Option B+, which consists of providing life-long antiretroviral treatment, regardless of their CD4 count or clinical stage. Our objective was to determine if Option B+ represents a cost-effective option.

Rationale, aims, and objectives: For a successful patient outcome, a high level of adherence to antiretroviral therapy (ART) is needed. A 2008 report in Tanzania indicated poor clinic attendance and a high lost to follow-up rate as major threats to optimal ART program effectiveness.

In developing countries, particularly in Africa, the provision of health services leans heavily towards today’s epidemics, including HIV and AIDS, malaria, tuberculosis and other infectious diseases. This calls for different approaches to the implementation of interventions from a public health perspective.

Background: Mortality and morbidity among HIV-exposed children are thought to be high in Malawi. We sought to determine mortality and health outcomes of HIV-exposed and unexposed infants within a PMTCT program.

The national scale up of antiretroviral therapy in Malawi is based on a public health approach, with principles and practices borrowed from the successful World Health Organization "DOTS" tuberculosis control framework.

Background: Maternal morbidity and mortality among HIV-infected women is a global concern. This study compared mortality and health outcomes of HIV-infected and HIV-uninfected mothers at 18–20 months postpartum within routine prevention of mother-to-child transmission of HIV (PMTCT) services in a rural district in Malawi.

Background: Mother-to-child transmission of HIV (MTCT) remains the most prevalent source of pediatric HIV infection. Most PMTCT (prevention of mother-to-child transmission of HIV) programs have concentrated monitoring and evaluation efforts on process rather than on outcome indicators. In this paper, we review service data from 28,320 children born to HIV-positive mothers to estimate MTCT rates.

Background: High quality program data is critical for managing, monitoring, and evaluating national HIV treatment programs. By 2009, the Malawi Ministry of Health had initiated more than 270,000 patients on HIV treatment at 377 sites.

Purpose of review: This review focuses on current status, progress, challenges and opportunities in global pharmacovigilance for HIV/AIDS treatment.

Objective: The objective of this review is to produce evidence on the prevalence and trends in the availability of substandard and counterfeit antimicrobials in the global market and its consequences on key public health interventions in developing countries.

In 2004, Malawi began scaling up its national antiretroviral therapy (ART) program. Because of limited treatment options, population-level surveillance of acquired human immunodeficiency virus drug resistance (HIVDR) is critical to ensuring long-term treatment success. The World Health Organization target for clinic-level HIVDR prevention at 12 months after ART initiation is ≥70%.

Treatment as Prevention (TasP) describes HIV prevention methods that use antiretroviral therapy (ART) in both HIV-positive and HIV-negative persons to decrease the risk of HIV transmission.

Positive health, dignity and prevention (PHDP) engages people who know they are living with HIV in prevention. It involves supporting HIV-positive people to learn and practice how to live healthily and minimize the risks of spreading the virus to others.

This technical brief summarizes the latest evidence on PMTCT of HIV in the Southern African region. It presents the current WHO guidance on antiretroviral use in pregnant HIV-positive women: Options A, B and B+. Option B+ is a new development, emerging from experiences in Malawi, which was the focus of much attention at the recent International AIDS Conference.

This technical brief makes the case for understanding behavior change approaches as necessary but insufficient methods of HIV prevention. The document describes how behavior change interventions may be more effective when they are used as part of a  combination prevention approach that is shaped by a social-ecological perspective on HIV prevention.

In 2007, WHO/UNAIDS recommended that male circumcision be considered an important new intervention for HIV prevention, and that countries with a high HIV prevalence, low rates of male circumcision, and heterosexual epidemics should consider scaling up male circumcision as part of a comprehensive HIV prevention package.

We need a dramatic change in thinking—and action from donors, policymakers, and program managers in the public, private, and nongovernmental (NGO) sectors—to focus on strengthening health systems in the countries most affected by HIV & AIDS. To meet the Millennium Development Goal of reversing the epidemic by 2015, we must change how we design and deliver services.

These guidelines provide standards for HIV prevention program implementation for non-governmental organizations and civil society organizations, against which services provided to the target populations can be monitored and evaluated to ensure quality and client satisfaction.

INSIDE STORY tells the story of Kalu, a rising Kenyan footballer, who moves from rural Kenya to urban Johannesburg to follow his dream and support his family. His path becomes more challenging when he falls in love with the coach’s daughter Ify and subsequently finds out he is HIV-positive.

Mobile health (mHealth) is the provision of health services and information via mobile and wireless technologies. The mobile phone has become ubiquitous in Africa, making mHealth an important tool with which to impact the health of Africans. When applied correctly, mHealth can make real contributions to improved health outcomes. 

Nigeria is home to 17.5 million orphans and vulnerable children (OVC). According to the Federal Ministry of Women Affairs and Social Development, one in every four children in Nigeria is considered vulnerable due to unmet needs for nutrition, education, shelter, care, or support. The Need for New Solutions

Nigeria is home to 17.5 million children who are considered vulnerable due to unmet needs for food, shelter, education, protection, or care With 3.4 million citizens living with HIV & AIDS, Nigeria has the second highest HIV burden in the world.

Pages